This study confirms proteostasis intermediates, chiefly HSP70, as chaperones for noncanonical IL-33 secretion and activity that may be amenable for therapeutic targeting in the chronic airway diseases COPD and asthma. The gene discussed is HSPA1A; the disease is chronic obstructive pulmonary disease.